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Mice homozygous for a null mutation in the PU.1 gene
die during fetal development by 18.5 days post coitum
(d.p.c.) and lack B, T, and myeloid progenitors. (ScottSummary
et al., 1994, 1997). PU.1/ fetal liver contains reduced
numbers of multipotential lymphoid-myeloid progeni-Development of the lymphoid system is dependent on
tors (AA4.1, Lin–). Furthermore, these mutant progeni-the Ets family transcription factor PU.1. We demon-
tors fail to proliferate and differentiate into pro-B cellsstrate that PU.1/ hematopoietic progenitors fail to
in response to stromal contact and Interleukin-7 (IL-7)express IL-7R transcripts. Promoter and chromatin
(Scott et al., 1997). There are two mutually nonexclusivecrosslinking analyses suggest that PU.1 directly regu-
explanations for the defects to lymphoid developmentlates transcription of the IL-7Rgene. Retroviral trans-
in PU.1/ fetuses. First, PU.1 might regulate lymphoidduction of IL-7R into PU.1/ progenitors restores
differentiation by functioning at the top of a geneticIL-7-dependent proliferation and induces, at low fre-
hierarchy to control expression of downstream regula-quency, the generation of pro-B cells undergoing an
tors such as E2A, EBF, and Pax5. Alternatively, PU.1apparently normal program of differentiation. Although
may regulate genes necessary for survival and prolifera-the related factor Spi-B can substitute for PU.1 in early
tion of lymphoid progenitors.B cell development, it is not required. These results dem-
Survival and proliferation of lymphoid progenitors inonstrate that PU.1 functions to regulate early B cell de-
fetal liver and bone marrow are dependent on cytokinevelopment in part by controlling the expression of the
signaling. Several cytokines have been demonstratedIL-7R gene.
to be important for developing B and T cells, including
stem cell factor (SCF), Flt-3 ligand, and IL-7 (reviewed
Introduction in Di Santo and Rodewald, 1998; Baird et al., 1999). IL-7
is produced primarily by stromal cells and is essential
Various transcription factors have been shown by loss- for the proliferation and differentiation of T and B cell
and gain-of-function experiments to be required for progenitors in vivo (Goodwin et al., 1990; von Freeden-
early B cell development, including PU.1, Ikaros, E2A, Jeffry et al., 1995). The receptor for IL-7 is heterodimeric,
EBF, and Pax5 (reviewed in O’Riordan and Grosschedl, consisting of an  chain (IL-7R) (Goodwin et al., 1990)
2000). Phenotypic analyses of mice with targeted null and a common  chain (c) (Noguchi et al., 1993; Kondo
alleles of genes encoding these factors have been used et al., 1994b). The c subunit is shared with the IL-2,
to order their developmental functions in the B lineage. IL-4, IL-9, and IL-15 receptors (reviewed in Sugamura
PU.1 and Ikaros appear to act upstream of E2A, EBF, et al., 1995), while the IL-7R chain has recently been
and Pax5 at the level of multipotential progenitors (Scott found to be shared by the thymic stromal lymphopoietin
et al., 1994; McKercher et al., 1996; Georgopoulos et (TSLP) receptor (Pandey et al., 2000; Park et al., 2000).
al., 1994; Wang et al., 1996). In contrast, E2A, EBF, and IL-7R is primarily expressed in fetal liver and bone
Pax5 function in B lineage progenitors (Zhuang et al., marrow common lymphoid progenitors (CLPs), T lineage
1994; Bain et al., 1994; Lin and Grosschedl, 1995; Nutt cells, and developing B cells (Mebius et al., 2001; Kondo
et al., 1997, 1999). E2A, EBF, and Pax5 directly control et al., 1997b; Sudo et al., 1993), while c is more broadly
transcription of early B cell genes (mb-1, B29, VpreB, expressed in various hematopoietic lineages (He et al.,
5, RAG-1, and RAG-2) as well as their own hierarchical 1995; Kondo et al., 1994a). Targeted mutations of either
expression (reviewed in O’Riordan and Grosschedl, the IL-7R (Peschon et al., 1994; Maki et al., 1996) or
2000). E2A appears to directly regulate transcription of c (DiSanto et al., 1995; Cao et al., 1995) genes result
the EBF gene (Kee and Murre, 1998) and EBF in turn is in a profound early block to B and T cell development.
implicated in activating expression of the Pax5 gene Ectopic expression of bcl-2 partially restores T cell
(O’Riordan and Grosschedl, 1999). PU.1 and Ikaros do but not B cell development (Akashi et al., 1997; Mara-
not appear to regulate each others’ expression (Scott skovsky et al., 1997; Kondo et al., 1997a). This result
suggests that IL-7 signaling is required not only for sur-et al., 1997; Nichogiannopoulou et al., 1999) and may
vival and proliferation of B lineage progenitors but alsoact independently of one another. PU.1 has been impli-
for their differentiation.cated in regulating the activity of the IgH intronic en-
PU.1/ hematopoietic progenitors have been shown
to be impaired in the expression of several myeloid cyto-1Correspondence: hsingh@midway.uchicago.edu
kine receptor genes including GM-CSFR, G-CSFR, and2 Present address: Department of Molecular Genetics, Biochemistry
c-fms (DeKoter et al., 1998). Therefore we examined theand Microbiology, The University of Cincinnati, 231 Albert Sabin
Way, Cincinnati, Ohio 45267. possibility that the defect to B and T cell development
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Figure 1. Analysis of Early B Lineage Gene Expression in PU.1/ and PU.1/ Hematopoietic Progenitors
Total RNA was prepared from whole 14.5 d.p.c. fetal liver (PU.1/) or from lineage-depleted (Lin) fetal liver progenitors from PU.1/ and
PU.1/ fetuses. The indicated transcripts were analyzed by RT-PCR after normalization with -actin.
in PU.1/ progenitors might be partly due to failed ex- is restricted to B cells within the hematopoietic system
(Hagman et al., 1993; Adams et al., 1992), whereas Ikarospression of genes encoding lymphoid cytokine recep-
tors. We show that PU.1–/– progenitors are defective in and E2A genes are expressed in multiple hematopoietic
lineages (Nichogiannopoulou et al., 1999; Murre et al.,expression of the IL-7R gene. Retroviral transduction
of IL-7R into PU.1/ progenitors restores their IL-7- 1989). These results extend our previous analysis (Scott
et al., 1997) and suggest that B lymphoid progenitorsdependent proliferation and at low frequency their differ-
entiation into pro-B cells that express the mb-1, B29, are absent in PU.1/ fetal liver.
To determine whether PU.1/ hematopoietic progen-VpreB, 5, RAG-1, and RAG-2 genes and undergo IgH
D-J rearrangement. IL-7R-rescued differentiation does itors express genes encoding cytokine receptors involved
in lymphoid development, RT-PCR analysis was per-not require the related Ets factor Spi-B. These results
demonstrate that PU.1 regulates early B cell development formed for IL-7R subunits (IL-7R, c) and Flt3. c and
Flt3 were expressed in PU.1/ progenitors (Figure 1C).in part by controlling the expression of the IL-7R gene.
The lower levels of Flt3 transcripts are likely due to a
reduction in Flt3 progenitors in PU.1/ fetal liver (K. Me-Results
dina and H.S., unpublished data). Strikingly, expression
of IL-7R transcripts was undetectable in PU.1/ pro-PU.1/ Hematopoietic Progenitors Fail to Express
genitors even after two rounds of PCR amplificationIL-7R Transcripts
(Figure 1C and data not shown). This result could beTo define the nature of the block to B cell development
due to the absence of lymphoid progenitors in PU.1/in PU.1/ fetuses, we prepared RNA from multipotential
fetal liver. Alternatively, PU.1 could directly regulate ex-progenitors (Lin) of 14.5 d.p.c. PU.1/ or PU.1/ fetal
pression of the IL-7R gene and therefore the absenceliver using a lineage depletion protocol (DeKoter and
of lymphoid progenitors in PU.1/ fetal liver would beSingh, 2000). RT-PCR analysis showed that genes en-
due in part to the failed expression of the IL-7R.coding B cell receptor-associated proteins (mb-1, B29,
VpreB, and 5) as well as the recombinase (RAG-1 and
RAG-2) were not expressed in PU.1/ progenitors (Fig- PU.1 Directly Regulates Transcription
of the IL-7R Geneure 1A). Genes encoding the transcription factors Ikaros
and E47 were expressed in PU.1/ progenitors at levels To explore if PU.1 directly regulates transcription of the
IL-7R gene, the DNA sequence spanning the transcrip-comparable to PU.1/ controls whereas EBF transcripts
were barely detectable and Pax5 transcripts were ab- tional start site (-2495 to 946, Pleiman et al., 1991)
was examined for potential PU.1 binding sites using asent (Figure 1B). The expression of EBF and Pax5 genes
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position-weight matrix algorithm (Ludwig et al., 2000). IL-7R transcripts in PU.1/ progenitors, suggest that
PU.1 directly activates transcription of the IL-7R gene.Two putative sites were identified, located at 914
and 763 relative to the transcription start site (Figure
2A). Comparison with the human IL-7R promoter se- Retroviral Transduction of PU.1/ Progenitors
quence (Puel et al., 1998) revealed a conserved region with IL-7R Restores IL-7-Dependent Proliferation
around site 2 but not site 1. We note that site 2 is located and Differentiation into Pro-B Cells
at positions –182 and –180 relative to the translational To test if restoration of IL-7R expression might be suffi-
start sites in the murine and human genes, respectively. cient to rescue IL-7-dependent proliferation of PU.1/
Gel shift analysis with oligonucleotide probes containing progenitors, we utilized murine stem cell virus (MSCV)
these sequences revealed that PU.1 bound the IL-7R based vectors (Hawley et al., 1994) that contained PU.1
gene site 2 with a higher affinity than site 1 (Figure 2B). or IL-7R cDNAs (Figure 4A). The control and PU.1 ret-
The IL-7R site 2 has a comparable affinity for PU.1 as roviral vectors contain a GFP gene whose expression is
the B site in an Ig  gene enhancer (Figure 2B). We made possible by an internal ribosome entry site (IRES)
note that the IL-7R site 2, and not a mutant version (Pear et al., 1998). The IL-7R vector was constructed
(see below), is specifically bound by endogenous PU.1 without an IRES-GFP cassette to facilitate secondary
protein in nuclear extracts from 38B9 pro-B cells (data transductions using GFP based vectors. Lin PU.1/
not shown). Therefore the murine IL-7R gene contains or PU.1/ hematopoietic progenitors were infected by
a high-affinity PU.1 binding site that lies between the coculture with retroviral packaging cells, then plated on
transcriptional and translational start sites. S17 cells with IL-7 (DeKoter and Singh, 2000). PU.1/
Several murine IL-7R promoter constructs were progenitors infected with control (MIGR1) virus prolifer-
tested for activity by transient transfection in B lineage ated and differentiated after 10–14 days into CD19 pro-
cell lines that express both PU.1 and the IL-7R. However, B cells (91.9  2.6, n  8) (Figure 4B, left panel), and
we detected very low activity of the promoter fragments CD19 Mac-1 macrophages (3.9  1.6%, n  8).
using this approach, preventing functional analysis of PU.1/ progenitors infected with MIGR1 virus failed to
the PU.1 binding sites in their native context. To test proliferate and died during the initial coculture (n  8).
whether site 2 could promote PU.1-dependent activa- Consistent with earlier analysis (Scott et al., 1997),
tion in vivo, three tandem repeats of the intact or mu- PU.1/ progenitors could not be propagated on stroma
tated site were cloned into a luciferase reporter con- with IL-7. In contrast, infection with MIG-PU.1 retrovirus
struct upstream of a minimal SV40 promoter. Transfection restored the ability of PU.1/ progenitors to proliferate
into 38B9 pro-B cells, which express both PU.1 and IL-7R, in response to IL-7 and stromal contact. PU.1/ progeni-
showed that the intact but not the mutated PU.1 binding tors transduced with PU.1 cDNA generated CD19 pro-
sites stimulated transcription by 10-fold (Figure 2C). In B cells (49.1  4.9%, n  8) (Figure 4B, middle panel),
NIH-3T3 cells, which do not express PU.1, ectopically as well as CD19 Mac-1 macrophages (29.0  4.5%,
expressed PU.1 stimulated transcription from the IL-7R n  8).
site 2 reporter construct (data not shown). Transduction with IL-7R cDNA restored the ability
To test whether the IL-7R gene binding site 2 is of PU.1/ progenitors to proliferate in response to IL-7
occupied by PU.1 protein in vivo, chromatin immunopre- and stromal contact. Interestingly, a small fraction (1.1
cipitation (ChIP) experiments were performed. Affinity- 0.9%, n  10) of the transduced PU.1/ cells expressed
purified anti-PU.1 antibody was used to immunoprecip- CD19 (Figure 4B, right panel), suggesting that pro-
tate chromatin prepared from IL-7-dependent, wild-type B cells are generated. However, most cells in these initial
pro-B cells. PCR analysis was performed on DNA pre- cultures did not express CD19 and morphologically re-
pared from immunoprecipitated chromatin using prim- sembled myeloid progenitors (data not shown). The ap-
ers spanning IL-7R gene PU.1 sites 1, 2, or exon 5. parent lower frequency of CD19 cells generated by
DNA fragments containing PU.1 site 2 were enriched by transduction of PU.1/ progenitors with IL-7R com-
an average of 12-fold (n  3) over fragments containing pared to PU.1 was confirmed by clonal analysis in which
site 1 or exon 5 sequences (Figure 3A). Therefore PU.1 PU.1/ progenitors were plated in methylcellulose cul-
associates with the IL-7R gene in pro-B cells. To deter- tures containing S17 stromal cells and IL-7 immediately
mine if PU.1 is bound to the IL-7R gene in other cellular following retroviral infection. Similar frequencies of IL-7-
contexts, we carried out ChIP analyses in WEHI-231 dependent colonies were generated from PU.1/ pro-
B cells and J774.1 macrophages. WEHI-231 cells do not genitors infected with either PU.1 or IL-7R cDNAs (data
express the IL-7R gene whereas low levels of IL-7R not shown). However, whereas 27% (15/56) of colonies
transcripts are detectable in J774.1 cells (data not obtained by transduction of PU.1 cDNA consisted of
shown). PU.1 was found to be crosslinked to the IL-7R CD19 cells, the frequency of CD19 colonies generated
gene site 2 in J774.1 cells but not in WEHI-231 cells with IL-7R cDNA was below detection (0/46). These
(Figure 3B). As additional controls for ChIP, we exam- results suggest that PU.1 is more efficient than the IL-7R
ined the binding of PU.1 to the Ig	 3
 enhancer as well at restoring the differentiation of PU.1/ progenitors
as the c-fms promoter in WEHI-231 and J774.1 cells. into pro-B cells.
PU.1 crosslinking to these regulatory elements was cell To analyze PU.1 or IL-7R-transduced PU.1/ pro-
type specific and correlated with the activity states of genitors in greater detail, cell lines were established by
these loci (Figure 3B and data not shown). In conclusion, passage on S17 stromal cells with IL-7 (Rolink et al.,
we have identified a functional high-affinity PU.1 binding 1991, 1993). Under these conditions, macrophages are
site in the murine IL-7R gene that is occupied by PU.1 lost after a few passages since the cells adhere to the
stroma and do not substantially proliferate. After twoin pro-B cells. These results, along with the absence of
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Figure 2. Analysis of PU.1 Binding Sites in the IL-7R Gene
(A) Schematic structure of the murine IL-7R gene promoter and downstream region indicating the PU.1 binding sites that were identified
using a position weight matrix algorithim. Sequence alignment of a conserved region spanning PU.1 binding site 2 in the murine and human
IL-7R genes is shown below the schematic.
(B) Gel shift assay with PU.1 binding sites in the IL-7R gene. A control high-affinity PU.1-binding site (B), PU.1 site 1, or PU.1 site 2
oligonucleotides were incubated with PU.1 protein generated by in vitro translation. Lanes 1, 5, and 9 contain free probes (P) whereas lanes
2, 6, and 10 represent incubations with control translation lysates (-). PU.1 translation lysates were used at two different concentrations, 2 l
() and 4 l ().
(C) PU.1 can activate transcription from the downstream IL-7R binding site. pGL3-based reporter constructs containing three tandem copies
of the wild-type or mutant PU.1 binding site 2 were transiently transfected into 38B9 pro-B cells. After normalization with a reference construct,
the luciferase activities of the two reporters are represented in relation to the control pGL3 reporter.
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transduced cell lines comprise of both CD19 and
CD19 cells, we reasoned that it is the former that likely
express B lineage genes and undergo a normal program
of B cell differentiation. To test this possibility, four
CD19 as well as nine CD19 clones were established
from early-passage cell lines and characterized in detail.
Clones were analyzed by RT-PCR for expression of the
B lineage genes mb-1, B29, VpreB, 5, RAG-1, and RAG-2
and the myeloid genes G-CSFR and FcRIII. As expected,
the CD19 clones expressed various B cell-specific genes
but did not express the myeloid genes G-CSFR or FcRIII
(Figure 6B). In contrast, CD19 clones expressed the
myeloid but not the B lineage genes. It should be noted
that expression of the G-CSFR gene is not absolutely
dependent on PU.1 (DeKoter et al., 1998). Additionally,
CD19 but not CD19 clones expressed the combina-
tion of CD24, CD43, VpreB, and c-kit on their surface
and exhibited DH-JH rearrangements at their IgH loci
(data not shown). Therefore the CD19 clones are pro-
B cells, whereas the CD19 clones are likely myeloid
progenitors that can proliferate in IL-7 as a consequence
of ectopic expression of IL-7R.
Spi-B Can Rescue Differentiation of PU.1/
Progenitors into Pro-B Cells and Macrophages
Spi-B and Spi-C (Prf) are Ets-family transcription factors
that share a higher degree of identity with PU.1 than
with any other Ets family member and appear to have
DNA binding specificities indistinguishable from that of
PU.1 (Ray et al., 1992; Ray-Gallet et al., 1995; Rao et
al., 1999; Hashimoto et al., 1999; Bemark et al., 1999).
Unlike PU.1, Spi-B and Spi-C are expressed exclusivelyFigure 3. Chromatin Immunoprecipitation Analysis of PU.1 Binding
to the IL-7R Gene in the lymphoid lineages (Su et al., 1996; Hashimoto et
al., 1999; Bemark et al., 1999). Spi-B transcripts were(A) Formaldehyde-crosslinked chromatin from wild-type fetal liver-
derived pro-B cells was immunoprecipitated using control rabbit detectable by RT-PCR in pro-B cell lines and clones
IgG or affinity purified anti-PU.1 (PU.1) antibodies as described in derived from IL-7R-transduced PU.1/ progenitors
the Experimental Procedures. PCR was performed on input and (Figure 7B and data not shown). In contrast, Spi-C tran-
immunoprecipitated DNA using primer pairs spanning PU.1 binding
scripts were not detectable in the rescued pro-B cellsite 1, binding site 2, and exon 5 in the IL-7R gene. PCR reactions
lines (Figure 7B, lanes 3 and 4). The latter result is notincluded -32P dCTP and the products were visualized by autoradi-
surprising since Spi-C appears to be expressed only inography. The control lane represents a PCR reaction conducted in
the absence of template DNA. mature B cells (Figure 7B, lane 1; Bemark et al., 1999).
(B) In vivo crosslinking of PU.1 in WEHI-231 B cells and J774.1 These results raised the possibility that Spi-B might pro-
macrophages. Formaldehyde-crosslinked chromatin was analyzed mote differentiation of IL-7R-transduced progenitors
as described in (A) using primer pairs spanning PU.1 binding sites
into pro-B cells in the absence of PU.1. To test thisin the IL-7R gene, Ig	 3’ enhancer, and c-fms promoter. The HPRT
hypothesis, PU.1/ progenitors were transduced withgene promoter was used as a negative control.
Spi-B cDNA. Spi-B rescued the ability of PU.1/ pro-
genitors to proliferate in response to stromal contact and
IL-7 and restored their ability to differentiate into CD19passages, PU.1/ and PU.1-rescued PU.1/ cell lines
contained exclusively CD19 pro-B cells (Figure 5A, top pro-B cells (35.3 1.5%, n 2) as well as Mac-1 macro-
phages (36.9 1.2%, n 2) (Figure 7A). The proportionspanel). Surprisingly, after two passages, cultures of
IL-7R-transduced PU.1/ cells contained a majority of the two cell types were similar to those obtained
using PU.1 cDNA (compare Figure 7A to Figure 4B).(61  4%, n  3) of CD19 cells, suggesting that these
cells proliferate more rapidly than the CD19 cells in the Furthermore, IL-7-dependent pro-B cell lines estab-
lished from Spi-B-transduced PU.1/ progenitors ex-population (Figure 5A, top panel). Both PU.1 and IL-7R-
transduced PU.1/ progenitors expressed IL-7R on pressed the identical complement of B lineage genes
and markers as described for their PU.1 counterpartstheir surface, albeit at lower levels than their control
counterparts (Figure 5A, bottom panel). RT-PCR analy- (data not shown). Finally, as we have reported for PU.1,
Spi-B-rescued macrophages expressed higher levels ofsis indicated that the IL-7R-transduced cell lines ex-
press various B lineage genes including mb-1, B29, GFP than their pro-B cell counterparts. This suggests,
as is the case for PU.1, that higher levels of Spi-B areVpreB, 5, RAG-1, RAG-2, EBF, and Pax5 (Figure 5B).
PCR analysis demonstrated that these cell lines were required for promoting macrophage than B cell develop-
ment (DeKoter and Singh, 2000). In conclusion, Spi-Balso undergoing DH-JH rearrangement at their immuno-
globulin heavy chain loci (Figure 5C). Since the IL-7R- can functionally substitute for PU.1 in promoting differ-
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Figure 4. Transduction with an IL-7R Retroviral Vector Restores IL-7-Dependent Proliferation of PU.1/ Progenitors
(A) Schematic structures of MSCV-based retroviral constructs. LTR, long terminal repeat; IRES, internal ribosomal entry site; and EGFP,
enhanced green fluorescent protein.
(B) Flow cytometric analysis of cultures of PU.1/ or PU.1/ progenitors after retroviral transduction. Lin progenitors were transduced with
MIGR1, MIG-PU.1, or MSCV-IL-7R retroviral vectors by coculture with retroviral packaging cell lines. Transduced progenitor cells were
expanded for 10–14 days on S17 stromal cells with Interleukin-7 (IL-7). Cells from these cultures were analyzed by flow cytometry for expression
of CD19 and GFP.
entiation of PU.1/ progenitors into pro-B cells and poietic progenitors also lack early B lineage gene tran-
macrophages. scripts, we suggest that loss of PU.1 results in impaired
survival and/or proliferation of lymphoid progenitors.
Consistent with this finding, PU.1 is expressed in puri-IL-7R-Dependent B Cell Development of PU.1/
fied bone marrow common lymphoid progenitors (CLPs)Progenitors Does Not Require Spi-B
(Akashi et al., 2000), pro-B cells (DeKoter and Singh,To directly test the requirement of Spi-B in the IL-7R
2000), and pro-T cells (Anderson et al., 1999). A require-rescue of early B cell differentiation, we infected
ment for PU.1 in the expression of the IL-7R in lymphoidPU.1/Spi-B/ (Garrett-Sinha et al., 1999) Linprogen-
progenitors would explain several aspects of theitors with the IL-7R retroviral vector. Transduction with
PU.1/ phenotype. IL-7R signaling is critical for B cellIL-7R rescued stromal cell and IL-7-dependent prolif-
development, is less stringently required for  T celleration of PU.1/Spi-B/ progenitors. After 10–14
development, and is dispensable for NK cell develop-days, a small fraction of these cells expressed CD19
ment (Peschon et al., 1994; Maki et al., 1996). In accord(1.0  0.7% , n  3). As was the case with IL-7R
with these findings, mutation of the PU.1 gene resultstransduction of PU.1/ progenitors, after two passages
in a profound block to B cell development (Scott et al.,the PU.1/Spi-B/ cell lines contained a high propor-
1994, 1997; McKercher et al., 1996; Colucci et al., 2001).tion (59  6%, n  2) of CD19 cells. PU.1/Spi-B/
In contrast, loss of PU.1 function impairs or delays, butCD19 cells were pro-B cells by all criteria described
does not completely block,  T cell development (Spainabove including expression of B cell-specific transcripts,
et al., 1999; McKercher et al., 1996). Finally, PU.1/DH-JH rearrangement, and cell surface expression of B
lineage markers (Figure 7B and data not shown). The res- progenitors are capable of differentiating into NK cells
cued cells did not express Spi-C transcripts (Figure 7B, after transplantation into recipient mice, although the
lanes 5 and 6). Therefore neither Spi-B nor Spi-C is NK cells that develop in these hosts are defective in
required for the differentiation of IL-7R-transduced, several ways, including in the expression of IL-7R (Col-
PU.1/ progenitors into CD19 pro-B cells. ucci et al., 2001). Therefore failed expression of IL-7R
in hematopoietic progenitors is likely a contributing
cause of the developmental defects of the lymphoidDiscussion
system in PU.1/ fetuses.
After transduction of PU.1/ hematopoietic progeni-In this study, we have investigated the underlying basis
tors with IL-7R cDNA, differentiation into pro-B cellsof the profound lymphoid deficiency caused by mutation
is observed, albeit at low frequency. These rare PU.1/of the PU.1 gene. We demonstrate that PU.1 is required
for the expression of the IL-7R. Since PU.1/ hemato- pro-B cells, after expansion, exhibit an apparently nor-
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Figure 5. IL-7R-Transduced, PU.1/ Progenitors Differentiate into Pro-B Cells
(A) Flow cytometric analysis of CD19 and IL-7R expression on control (PU.1/  MIGR1), PU.1-rescued (PU.1/  MIG-PU.1) and IL-7R-
rescued (PU.1/  MSCV-IL-7R) cell lines. IL-7R expression on IL-7R-rescued cells is shown after gating on CD19 or CD19 cells.
(B) RT-PCR analysis of B lineage gene expression. Total RNA was prepared from the cell lines indicated above as well as from the S17 stromal
cell line as a negative control. Transcripts for the indicated genes were analyzed as described in the legend to Figure 1. EBF expression in
a stromal cell line has been previously noted (Nutt et al., 1997)
(C) PCR analysis of immunoglobulin heavy-chain (IgH) D-J recombination. Genomic DNA was prepared from the cell lines described above,
as well as from the S17 stromal cell line as a negative control. DNA was analyzed by PCR using a primer 5’ to most DH segments and a
primer 3’ of JH4. PCR products were separated using agarose gel electrophoresis and visualized by Southern blotting with a radiolabeled
DHFL16-JH4 probe.
mal pattern of B lineage gene expression and IgH DNA induce IgH locus accessibility and transcription of the
Pax5 gene in pro-B cells (Corcoran et al., 1998). There-rearrangements. Furthermore, we demonstrate that
early B lineage differentiation can occur in the absence fore, loss of IL-7R expression caused by mutation of
the PU.1 gene likely results in defects in both prolifera-of the PU.1-related proteins Spi-B or Spi-C. These re-
sults suggest that PU.1 is not essential for expression tion and differentiation of lymphoid progenitors.
Although expression of IL-7R in PU.1/ progenitorsof other B lineage transcription factors, such as E2A,
EBF, or Pax5, and may not function in concert with them enables early B cell differentiation, significantly fewer
pro-B cells are generated in this case than by the resto-to regulate transcription of the mb-1, B29, 5, VpreB,
and Rag genes. Instead, PU.1 likely functions in a parallel ration of PU.1 expression. This could be due to the
following possibilities: (1) PU.1 can rescue more primi-pathway to regulate early B cell development by control-
ling the expression of the IL-7R as well as additional tive mutant progenitors than the IL-7R; (2) IL-7R pro-
motes survival of mutant progenitors that then undergogenes (see below). Restoration of IL-7R signaling in
PU.1/ progenitors can initiate or sustain the B lineage stochastic, PU.1-independent differentiation, which is
inefficient; or (3) ectopic expression of IL-7R redirectsdifferentiation program, albeit inefficiently. Interestingly,
the IL-7R is thought to provide two types of signals in the fate of nonlymphoid mutant progenitors. We note
that the defect to B cell development caused by muta-developing lymphoid progenitors, (1) proliferation, and
(2) differentiation (reviewed in Hofmeister et al., 1999). tion of PU.1 is more severe than that caused by loss of
the IL-7R, since bone marrow and thymus fromThese signals can be separated by mutation of specific
amino acid residues in the cytoplasmic tail of the recep- IL-7R/ mice does contain low frequencies of B and
T cells, respectively (Peschon et al., 1994; Maki et al.,tor (Corcoran et al., 1996). IL-7R signaling appears to
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Figure 6. Analysis of IL-7R-Transduced, PU.1/ Clones
(A) Flow cytometric analysis of CD19. IL-7R-transduced, PU.1/
clones were isolated by plating in methylcellulose. Left and right
panels show a CD19 and CD19 clone, respectively.
(B) RT-PCR analysis of lymphoid and myeloid gene expression in
IL-7R-transduced, PU.1/ clones. RNA was prepared from wild-
type pro-B cells, macrophages, or IL-7R-transduced, PU.1/ cells.
The CD19 and CD19 clones (lanes 4 and 5) were isolated from
Figure 7. Spi-B Can Promote Differentiation of PU.1/ Progenitors
the IL-7R-transduced, PU.1/ cell line (PU.1/  MSCV-IL-7R,
into Pro-B Cells, but Is Not Required
lane 3). The indicated transcripts were analyzed by RT-PCR after
(A) Spi-B rescues IL-7-dependent proliferation of PU.1/ progeni-normalization with -actin.
tors and promotes differentiation into pro-B cells as well as macro-
phages. A schematic structure of the MIG-Spi-B retroviral construct
is shown. Lin progenitors (PU.1/ or PU.1/) were transduced1996). Therefore, mutation of the PU.1 gene likely results
with MIGR1 or MIG-Spi-B retroviral vectors by coculture with pack-
in defects in lymphoid progenitors in addition to loss of aging cell lines. Transduced progenitor cells were expanded for
IL-7R expression. The PU.1 mutation may also cause 10–14 days on S17 stromal cells with IL-7. Cells were analyzed by
flow cytometry for expression of CD19 and GFP (upper panels) orarrest of lymphoid development at a stage earlier than
Mac-1 and GFP (lower panels).that caused by mutation of IL-7R. We have previously
(B) RT-PCR analysis of gene expression in IL-7R-transduced, PU.1/suggested that mutation in PU.1 causes developmental
or PU.1/Spi-B/ cell lines. Total RNA was prepared from wild-typearrest at the level of a common lymphoid-myeloid pro-
splenocytes as a positive control, S17 stromal cells as a negative
genitor (Singh, 1996; Scott et al., 1997). Interestingly, control, or from the indicated PU.1/ and PU.1/Spi-B/ pro-B cell
the IL-7R is first expressed on a fetal hematopoietic lines. PU.1, Spi-B, Spi-C, and Pax5 transcripts were analyzed as
described in the legend to Figure 1.progenitor with both lymphoid and myeloid potential
(Mebius et al., 2001). These cells might be more severely
affected in PU.1/ than in IL-7R/ fetuses as a result
of defects in expression of additional genes, some of expression of IL-7R as well as additional genes that may
promote the interaction of lymphoid progenitors withwhich may encode adhesion receptors such as integrins
(Fisher et al., 1999). Thus we favor the possibility that stromal cells.
PU.1 is the first transcription factor shown to regulatePU.1 rescues more primitive mutant progenitors to dif-
ferentiate into pro-B cells by virtue of regulating the the IL-7R gene in lymphoid progenitors. Although the
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promoter sequence of the IL-7R gene was reported Thus it appears that there are fewer PU.1 target genes in
several years ago, the only transcription factor binding developing B lineage cells compared with macrophages
site to be analyzed was an interferon regulatory element and granulocytes. We have previously demonstrated
capable of binding IRF-1 and IRF-2 (Pleiman et al., 1991). that higher concentrations of PU.1 protein are required
IRF-2/ mice have reduced numbers of IL-7-responsive to promote macrophage than Bcell development (DeKoter
progenitors but it has not been determined if they have and Singh, 2000). Assuming that the levels of nuclear PU.1
impaired expression of the IL-7R (Matsuyama et al., protein are limiting, we speculate that the requirement
1993). The site in the IL-7R gene bound by PU.1 in for a higher concentration threshold of PU.1 protein in
vitro as well as in vivo resides approximately 800 bp macrophage differentiation may reflect the need for ef-
downstream of the transcription start site. Intriguingly, fective occupancy of a larger set of genomic targets.
this site is embedded in a conserved block of DNA se-
Experimental Proceduresquence (100 bp) in the murine and human IL-7R genes.
Therefore, this region may represent a PU.1-dependent
Cell Linesenhancer that regulates expression of the IL-7R gene.
The retroviral packaging cell lines Phoenix (Kinsella and Nolan, 1996)
It should be noted that the transcription factors E2A, and GPE-86 (Markowitz et al., 1988), as well as NIH-3T3 cells,
EBF, and Pax5, although required for early B lineage were maintained in complete DMEM medium. S17 stromal cells
differentiation, do not appear to regulate the expression (Collins and Dorshkind, 1987), J558-IL-7 cells (Winkler et al., 1995),
and 38B9 pro-B cells (Alt et al., 1981) were maintained in completeof the IL-7R (Bain et al., 1994; Lin and Grosschedl, 1995;
RPMI-1640 medium. All complete media contained 10% fetal bovineO’Riordan and Grosschedl, 1999; Nutt et al., 1997).
serum (Hyclone), 100 U/ml penicillin/streptomycin, 2 mM L-gluta-Therefore, control of IL-7R expression in early lymphoid
mine, 5  105 M -mercaptoethanol, and 0.5 mM HEPES.
development is a function uniquely provided by PU.1.
We note that in later stages of B cell and T cell develop- Construction of Retroviral Vectors and Packaging Cell Lines
ment, expression of PU.1 no longer correlates with The murine stem cell virus-internal ribosomal entry site-green fluo-
rescent protein (MSCV-IRES-GFP, MIGR1) retroviral vector has beenIL-7R expression. As pro-B cells differentiate into pre-
described (Pear et al., 1998). MIG-PU.1 was generated by blunt-endB cells, expression of IL-7R is downregulated (Sudo
ligation of HA-tagged PU.1 cDNA into the HpaI site of MIGR1. MSCVet al., 1993) while PU.1 continues to be expressed (our
was generated by removal of the PGK-neo cassette from MSCV-unpublished data). Furthermore, as thymic T cells ma- neo vector (Hawley et al., 1994) by digestion with BglII and BamHI.
ture, they shut down expression of PU.1 while IL-7R The ends were blunted and the plasmid was recircularized using
continues to be expressed at selected stages of positive T4 DNA ligase. MSCV-IL-7R was generated by blunt-end ligation
of IL-7R cDNA (Lo et al., 1999) into the HpaI site of MSCV. Murineselection and then in mature peripheral T cells (Sudo
Spi-B cDNA was amplified by RT-PCR using RNA prepared fromet al., 1993). Therefore other transcription factors must
IL-7-dependent pro-B cell lines, high-fidelity TAQ polymerase (Ta-regulate IL-7R gene expression during later stages of
KaRa), and primers complementary to the 5’ and 3’ ends of theB or T cell differentiation.
cDNA (see Supplemental Table S1 at http://www.immunity.com/cgi/
Retroviral transduction of PU.1/ progenitors with content/full/16/2/297/DC1). These primers incorporated NotI and
Spi-B cDNA led to the development of both pro-B cells ApaI restriction sites into the cDNA for cloning into pcDNA3-HA
and macrophages. Therefore Spi-B is capable of func- (Brass et al., 1996). HA-tagged Spi-B cDNA was cut from pcDNA3-
HA-Spi-B by HindIII and ApaI digestion and subcloned into the HpaItionally substituting for PU.1 in B cell as well as macro-
site of MIGRI by blunt-end ligation.phage development. Previously, PU.1 and Spi-B have
To establish retroviral packaging cell lines, retrovirus producedbeen suggested to have redundant functions in regulat-
by transient transfection of Phoenix cells was used to infect GPE-ing B cell activation and terminal differentiation (Garrett-
86 cells after overnight treatment with tunicamycin. After 2 days,
Sinha et al., 1999). Murine PU.1 and Spi-B are 67% the brightest GFP-expressing cells were sorted using a Becton-
identical in their Ets domains and have indistinguishable Dickinson FACScalibur system and expanded under gpt selection.
DNA binding specificities (Ray-Gallet et al., 1995; Rao Sorted cell lines were analyzed periodically to ensure they consisted
of GFP cells. The retroviral titer of each cell line was determinedet al., 1999). PU.1 and Spi-B are therefore a new example
by infection of NIH-3T3 cells followed by flow cytometric analysisof related transcription factors that serve different func-
of GFP. Expression of HA-tagged PU.1 or Spi-B in the MIG-PU.1 andtions in vivo as a result of their differing expression
MIG-Spi-B packaging cell lines was confirmed by Western blottingpatterns. For example, GATA-2 and GATA-3 transcrip- using anti-PU.1 and/or anti-HA antibodies. Expression of IL-7R
tion factors can partially substitute for GATA-1 defi- by the MSCV-IL-7R packaging cell line was confirmed by flow
ciency when expressed in GATA-1/ erythroid cells but cytometry.
do not compensate in vivo because they are not highly
Isolation of Lineage-Depleted Fetal Hematopoietic Progenitorsexpressed in the erythroid lineage (Tsai et al., 1998;
PU.1/ or PU.1/Spi-B/ mice were mated to produce PU.1/Takahashi et al., 2000). It remains to be determined if Spi-
and PU.1/Spi-B/ fetuses as well as control littermates. The pres-B expressed under the control of PU.1 regulatory elements
ence of a vaginal plug on the morning after matings was taken as 0.5
can fully complement the PU.1 mutation in vivo. d.p.c. Fetuses (14.5 d.p.c.) were phenotyped using flow cytometric
Taken together with previous findings, the results re- analysis of Mac-1 expression (Scott et al., 1997). Genotyping of
ported here demonstrate that a major function of PU.1 PU.1 alleles was performed by PCR using a combination of three
in hematopoiesis is to regulate expression of myeloid primers recognizing PU.1 exon 4, PU.1 exon 5, and the PGK pro-
moter (Supplemental Table S1 at http://www.immunity.com/cgi/and lymphoid cytokine receptor genes. However, unlike
content/full/16/2/297/DC1). Genotyping of Spi-B alleles was per-the case with IL-7R, transduction of PU.1/ progeni-
formed using a combination of three primers recognizing Spi-B exontors with c-fms or GM-CSFR cDNAs restores cytokine-
5, Spi-B exon 6, and the PGK promoter (Supplemental Table S1 at
dependent proliferation but not differentiation (DeKoter http://www.immunity.com/cgi/content/full/16/2/297/DC1). Lin-
et al., 1998; Singh et al., 1999). PU.1 controls myeloid eage depleted (Lin–) hematopoietic progenitors were isolated from
development by regulating transcription of multiple 14.5 d.p.c. fetal liver suspensions as described previously (DeKoter
and Singh, 2000).genes in addition to those encoding cytokine receptors.
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Infection and Culture of Lineage-Depleted Fetal assay with double-stranded oligonucleotide probes containing the
PU.1 binding sites B (Brass et al., 1996), IL-7R site 1, or IL-7RHematopoietic Progenitors
GPE-86 lines were irradiated using 2000 rad from a Cesium source site 2 (see Supplemental Table S1 at http://www.immunity.com/cgi/
content/full/16/2/297/DC1). Synthetic complementary oligonucleo-and plated at 1.5  105 cells/well in a 24-well plate (Corning-Costar)
and incubated overnight. Lin fetal liver progenitors (105) were intro- tides were annealed and end-labeled with -32P dCTP using the
Klenow fragment. DNA binding reactions were performed for 30 minduced in each well and infected by coculture for 2 days in complete
IMDM medium containing 4 g/ml polybrene and 5% conditioned at 25C and contained 5  105 cpm of probe, 2 or 4 l of IVT PU.1
protein, and 0.5 g of poly-(dI-dC) in a final volume of 20 l. Themedium from J558-IL-7 cells. Infected cells were removed by gentle
pipetting and transferred onto a monolayer of irradiated S17 stromal resulting complexes were resolved on a 5% native polyacrylamide
gel using 1 TGE buffer, at 150V for 2 hr.cells. Cultures were fed with fresh IL-7-containing medium every 4
days and analyzed after 10–14 days. All experiments were performed
at least three times unless otherwise indicated. The statistics shown Transient Transfection Analysis
represent means and standard error of n experiments. pGL3 (Promega) derivatives were constructed so as to have a 3-fold
direct repeat of wild-type (5
-AAACAGGAAGTCTG-3
) or mutant (5
-
Establishment of IL-7-Dependent Cell Lines and Clones AAACACGACGTCTG-3
) PU.1 site 2, upstream of the SV40 pro-
Cells from 10-14 day cultures of PU.1/ and PU.1/, or PU.1/Spi- moter. 38B9 pro-B cells (5  106) were transfected with 10 g of
B/ fetal hematopoietic progenitors rescued with PU.1, Spi-B, or the various reporter constructs and 1 g pRL-TK (Promega) as an
IL-7R cDNAs were expanded and passaged by plating on mono- internal control. Transfections were performed by electroporation
layers of irradiated S17 stromal cells and IL-7-containing medium using a Bio-Rad Gene Pulser in 1 ml cuvettes at 25 F and 1500V
as described above. IL-7-dependent cell lines were passaged by settings. The cells were lysed 24 hr after transfection and analyzed
plating at 1.5  105 cells/ml every 4 days. To generate pro-B cell for both firefly and Renilla luciferase activities using a dual luciferase
clones, early-passage IL-7-dependent cell lines were plated at low assay kit (Promega) and an Analytical Luminescence Laboratory
density (up to 100 cells) in 35 mm tissue culture dishes with irradiated Monolight 1500 tube luminometer. Transfections were done in dupli-
S17 stromal cells and IL-7-containing methylcellulose medium cate at least three independent times.
(StemCell Technologies). After 7–10 days, well-separated colonies
were picked and propagated as described above.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation assays were performed as de-Antibodies and Flow Cytometry
scribed (Boyd et al., 1998) with a few modifications. Cells (5–10 Flow cytometric analyses were performed on single-cell suspensions
107) were crosslinked for 10 min at room temperature by addingwashed in Dulbecco’s phosphate-buffered saline containing 0.05 M
paraformaldehyde (1% final) with gentle rocking. The crosslinkingEDTA and 0.5% LPS-free bovine serum albumin (Sigma). Cells were
reaction was stopped by the addition of glycine to a final concentra-stained with phycoerythrin (PE) or biotin-conjugated antibodies and
tion of 0.125 M. Cells were washed in cold PBS and nuclei werestreptavidin(SA)-PE, SA-allophycocyanin (APC), or PE-conjugated
isolated with cell lysis buffer (5 mM Pipes [pH 8.0], 85 mM KCl, andanti-rat secondary reagents. Propidium iodide (Molecular Probes)
0.5% NP40). Nuclei were resuspended in lysis buffer (50 mM Triswas used to exclude dead cells from analysis. Anti-mouse mono-
[pH 8.0], 10 mM EDTA, and 1% SDS) and sonicated using a Bransonclonal antibodies used in this study were purchased from Phar-
250 sonifier for two 30 s pulses at constant power and an outputmingen unless otherwise indicated and used according to the manu-
setting of 5 to generate a mean DNA size of 0.2–1.0 kb. Chromatinfacturer’s instructions. The antibodies used included RA3-6B2-
was diluted 1 to 3 in dilution buffer (0.01% SDS, 1% Triton X-100,biotin (B220, CD45RA); 145-2C11-biotin (CD3); H129.19-biotin
2 mM EDTA, 150 mM NaCl, and 20 mM Tris [pH 8.0]), precleared(CD4); 53-7.3-biotin (CD5); 53-6.7-biotin (CD8a); M1/70-PE (CD11b,
with Staph A cells (Roche) for 15 min at 4C. Chromatin from 5 Mac-1); Ter119-biotin; RBC-8C5-biotin (Gr-1); 1D3-PE (CD19);
106 cells was incubated with 1 g of control rabbit IgG (Santa Cruz)VP245 (rat anti-VpreB [Karasuyama et al., 1993], gift of Y. Argon); M1/
or affinity purified anti-PU.1 antibodies for 3 hr, followed by addition69-PE (CD24, HSA); S7-PE (CD43, leukosialin); B12-1-biotin (CD127,
of Staph A cells for 15 min at room temperature. The immunoprecipi-IL-7R); and II/41-biotin (Ig).
tates were collected by centrifugation and subjected to six rounds
of washes. DNA was purified from the input and the immunoprecipi-
RT-PCR Analysis tates by phenol/chloroform extraction and ethanol precipitation after
RNA was isolated using RNAzol (Tel-Test) and reverse-transcribed reversal of crosslinking by heating at 67C for 5 hr and a proteinase K
using a first-strand cDNA synthesis kit (Pharmacia-Amersham). RNA digestion, 45C for 2 hr. Input and immunoprecipitated DNA samples
concentration was normalized between samples by performing 20 were dissolved in 100 l TE and 5 l of each was analyzed by
or 25 cycles of PCR on serial dilutions of cDNA using primers for semiquantitative PCR (30–35 cycles) with primer pairs derived from
-actin. PCR was performed for 30 cycles using primers and condi- the IL-7R, c-fms, Ig	, and hprt genes (see Supplemental Table
tions described in Supplemental Table S1 at http://www.immunity. S1 at http://www.immunity.com/cgi/content/full/16/2/297/DC1). For
com/cgi/content/full/16/2/297/DC1. PCR products were visualized quantitation, 0.1 l of -32P dCTP (6000 Ci/mmole) was added to
by ethidium bromide staining and digital photography (Kodak the PCR reactions and the PCR products were visualized by autora-
DC120). Each RT-PCR analysis was performed with at least three diography and analyzed using a PhosphorImager (Molecular Dy-
independent RNA samples. namics) after being resolved on a 6% polyacrylamide gel.
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